SSi Mantra — Regulatory decision
Q1 2027
The Company anticipates that the FDA will complete its review of the Company's AINN response and the Company's 510(k) submission for the SSi Mantra in the first quarter of 2027.Source filing
SSII biotech catalysts & pipeline
SS INNOVATIONS INTERNATIONAL INC · Data as of 2026-10-25